Kidron Miriam 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Kidron Miriam
DirectorChief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-03+72,000→ 72,000 totalExercise: $13.89Exp: 2032-01-03→ Common Stock (72,000 underlying) - Award
Common Stock
2022-01-03+42,000→ 183,666 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 10,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]The Stock Option will vest in 4 installments as follows: 18,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.